Education
About Us
Working with TipRanks
Follow Us
Alan Neil Rabinowitz Insider Profile
4 Followers
Alan Neil Rabinowitz, Director at VentriPoint Diagnostics, holds 110.00K shares in VentriPoint Diagnostics (Ticker: TSE:VPT). Most recently, Alan Neil Rabinowitz Bought 110,000 shares of VentriPoint Diagnostics on Oct 05, 2019 for an estimated value of C$16.50K.
Alan Neil Rabinowitz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Alan Neil Rabinowitz's holdings
Insider Roles
Director
Roles that Alan Neil Rabinowitz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Alan Neil Rabinowitz
Alan Neil Rabinowitz's Trading History
List of latest transactions for each holding click on a transaction to see Alan Neil Rabinowitz's performance on stock
You May Also Like
Alan Neil Rabinowitz insider profile FAQ
What is the percentage of profitable transactions made by Alan Neil Rabinowitz?
The percentage of profitable transactions made by Alan Neil Rabinowitz is ―.
What is the average return per transaction made by Alan Neil Rabinowitz?
The average return per transaction made by Alan Neil Rabinowitz is ―.
What stocks does Alan Neil Rabinowitz hold?
Alan Neil Rabinowitz holds: TSE:VPT stocks.
What was Alan Neil Rabinowitz’s latest transaction?
Alan Neil Rabinowitz latest transaction was an Informative Buy of C$16.50K.
What was Alan Neil Rabinowitz's most profitable transaction?
Alan Neil Rabinowitz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Alan Neil Rabinowitz's role in VentriPoint Diagnostics?
Alan Neil Rabinowitz's role in VentriPoint Diagnostics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.